Nu Skin
NUS
196 hedge funds and large institutions have $442M invested in Nu Skin in 2025 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 63 increasing their positions, 70 reducing their positions, and 20 closing their positions.
80% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 20
8% more funds holding
Funds holding: 181 → 196 (+15)
7% more capital inflows, than outflows
Capital inflows: $50.7M | Capital outflows: $47.5M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.19% less ownership
Funds ownership: 73.38% → 73.19% (-0.19%)
10% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 70
69% less call options, than puts
Call options by funds: $445K | Put options by funds: $1.43M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Portolan Capital Management
Boston,
Massachusetts
|
+$6.27M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$5.26M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$2.71M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.58M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$7.9M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$4.46M |
| 3 |
JP Morgan Chase
New York
|
-$2.86M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$2.81M |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.52M |
NUS Hedge Fund Activity: Q3 2025 in Review
196 of the 7,661 institutional investors tracked by Wall St. Rank reported a position in Nu Skin (NUS) for Q3 2025, worth a combined $442M — up 52% from $290M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new NUS positions and 20 closed out — a net gain of 16 holders — while 63 added to existing stakes and 70 trimmed.
The largest buyer was Portolan Capital Management, opening a new position worth an estimated $6.27M. The largest seller was D.E. Shaw & Co, cutting an estimated $7.9M.
- 196 institutional investors held Nu Skin (NUS) as of Q3 2025, up from 181 in Q2 2025.
- Funds reported $442M of Nu Skin stock for Q3 2025, up 52% quarter-over-quarter.
- 36 funds opened new Nu Skin positions in Q3 2025 and 20 closed out, a net change of +16 holders.
- The largest Nu Skin buyer in Q3 2025 was Portolan Capital Management, an estimated $6.27M added.
- The largest Nu Skin seller in Q3 2025 was D.E. Shaw & Co, an estimated $7.9M sold.
Based on aggregated 13F filings for Q3 2025.